Aixia Zhai

999 total citations
39 papers, 797 citations indexed

About

Aixia Zhai is a scholar working on Molecular Biology, Epidemiology and Immunology. According to data from OpenAlex, Aixia Zhai has authored 39 papers receiving a total of 797 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Epidemiology and 11 papers in Immunology. Recurrent topics in Aixia Zhai's work include Cancer-related molecular mechanisms research (8 papers), interferon and immune responses (7 papers) and MicroRNA in disease regulation (6 papers). Aixia Zhai is often cited by papers focused on Cancer-related molecular mechanisms research (8 papers), interferon and immune responses (7 papers) and MicroRNA in disease regulation (6 papers). Aixia Zhai collaborates with scholars based in China, Australia and United States. Aixia Zhai's co-authors include Zhijuan Li, Changlong Bi, Yue Zhou, Tingting Wang, Jing Chen, Yili Fu, Bo Li, Fengmin Zhang, Lanlan Wei and Wuqi Song and has published in prestigious journals such as PLoS ONE, Scientific Reports and The FASEB Journal.

In The Last Decade

Aixia Zhai

37 papers receiving 791 citations

Peers

Countries citing papers authored by Aixia Zhai

Since Specialization

Citations

This map shows the geographic impact of Aixia Zhai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aixia Zhai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aixia Zhai more than expected).

Fields of papers citing papers by Aixia Zhai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aixia Zhai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aixia Zhai. The network helps show where Aixia Zhai may publish in the future.

Co-authorship network of co-authors of Aixia Zhai

This figure shows the co-authorship network connecting the top 25 collaborators of Aixia Zhai. A scholar is included among the top collaborators of Aixia Zhai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aixia Zhai. Aixia Zhai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Hepatitis B virus X protein (HBx)-mediated immune modulation and prognostic model development in hepatocellular carcinoma 2025 ·PLoS ONE ·Jianhua Zhong, Yuetong Li, Yang Liu, (unknown), (unknown), (unknown), Miao Qi, Yiming Lin, (unknown), (unknown), Changlong Bi, Aixia Zhai	1
2	Unveiling the anticancer potential of SGLT-2 inhibitors: mechanisms and prospects in clinical oncology—a narrative review 2025 ·European journal of medical research ·Jiaxin Li, Jie Qiao, (unknown), Jianhua Zhong, Ke Chen, (unknown), Yuetong Li, Ying Jin, Yingshui Yao, Aixia Zhai, Changlong Bi	1
3	Cathepsin B as a potential serum biomarker for early diagnosis and progression of diabetic foot ulcer complicated with peripheral vascular disease 2025 ·Scientific Reports ·Ying Jin, Yaqi Yao, (unknown), Jianhua Zhong, (unknown), Yang Liu, Yuetong Li, Jie Qiao, Aixia Zhai, Changlong Bi	0
4	Disulfidptosis-related gene SLC3A2: a novel prognostic biomarker in nasopharyngeal carcinoma and head and neck squamous cell carcinoma 2025 ·Frontiers in Oncology ·(unknown), (unknown), Liang Shi, Aixia Zhai, Chao Wu, Qian‐Ying Zhu	1
5	HDAC4: an emerging target in diabetes mellitus and diabetic complications 2025 ·European journal of medical research ·(unknown), Yuetong Li, Ke Chen, Ying Jin, (unknown), Yi‐Ling Wu, (unknown), (unknown), Jie Qiao, Aixia Zhai, Changlong Bi	3
6	Evaluation of dried blood spots for Epstein–Barr virus nucleic acid testing 2024 ·Journal of Clinical Virology ·Peng Mei, (unknown), Aixia Zhai, Qian‐Ying Zhu	0
7	Advanced multifunctional hydrogels for diabetic foot ulcer healing: Active substances and biological functions 2024 ·Journal of Diabetes ·Yuetong Li, Yuxin Leng, Yang Liu, Jianhua Zhong, (unknown), (unknown), Zhenlin Li, (unknown), (unknown), (unknown), Changlong Bi, Aixia Zhai	15
8	Evaluation of serum Epstein–Barr virus envelope glycoproteins antibodies and their association with systemic autoimmune diseases 2024 ·Journal of Medical Virology ·(unknown), (unknown), Yinfeng Kang, (unknown), (unknown), Aixia Zhai, Chao Wu, Mu‐Sheng Zeng, Qian‐Ying Zhu	2
9	SUV39H1 is a novel biomarker targeting oxidative phosphorylation in hepatitis B virus-associated hepatocellular carcinoma 2023 ·BMC Cancer ·Yanping Zhang, (unknown), (unknown), (unknown), Yuetong Li, Xin Yu, (unknown), Yang Liu, Zhenlin Li, Yilin Deng, (unknown), Changlong Bi, Chao Wu, Aixia Zhai	5
10	Research on the biological mechanism and potential application of CEMIP 2023 ·Frontiers in Immunology ·Yang Liu, Gang Hu, Yuetong Li, (unknown), (unknown), Zhenlin Li, (unknown), Jiaxin Li, Jianhua Zhong, (unknown), Yuxin Leng, Changlong Bi, Aixia Zhai	8
11	Immunodominant SARS‐CoV‐2‐specific CD4⁺ and CD8⁺ T‐cell responses elicited by inactivated vaccines in healthy adults 2023 ·Journal of Medical Virology ·Jie Ning, (unknown), Ying Chen, (unknown), Fang Zhang, Xingchi Chen, Liang Shi, Aixia Zhai, Bin Li, Chao Wu	7
12	The BBIBP-CorV inactivated COVID-19 vaccine induces robust and persistent humoral responses to SARS-CoV-2 nucleocapsid, besides spike protein in healthy adults 2022 ·Frontiers in Microbiology ·(unknown), Jie Ning, Ying Chen, Bin Li, Liang Shi, (unknown), Fang Zhang, Xingchi Chen, Aixia Zhai, Chao Wu	8
13	Epidemiology and prediction of multidrug-resistant bacteria based on hospital level 2022 ·Journal of Global Antimicrobial Resistance ·Ying Chen, Xingchi Chen, Liang Zheng, Shuhao Fan, (unknown), (unknown), Bin Li, Liang Shi, Aixia Zhai, Chao Wu	15
14	CXCL8, CXCL9, CXCL10, and CXCL11 as biomarkers of liver injury caused by chronic hepatitis B 2022 ·Frontiers in Microbiology ·(unknown), Ying Chen, Lele Cui, (unknown), (unknown), (unknown), Yanping Zhang, (unknown), (unknown), Zhenlin Li, Yang Liu, Yuetong Li, Changlong Bi, Chao Wu, Aixia Zhai	17
15	Down-regulation of suppressor of cytokine signaling 3 by miR-122 enhances interferon-mediated suppression of hepatitis B virus 2015 ·Antiviral Research ·(unknown), Aixia Zhai, Jun Qian, Aimei Li, Yujun Li, Wuqi Song, Hong Zhao, (unknown), (unknown), Qingmeng Zhang, Wenping Kao, Lanlan Wei, Fengmin Zhang, Zhaohua Zhong	29
16	MiR-122 Directly Inhibits Human Papillomavirus E6 Gene and Enhances Interferon Signaling through Blocking Suppressor of Cytokine Signaling 1 in SiHa Cells 2014 ·PLoS ONE ·Junming He, Yuting Ji, Aimei Li, Qingmeng Zhang, Wuqi Song, Yujun Li, Hongxin Huang, Jun Qian, Aixia Zhai, Xin Yu, Jinyun Zhao, (unknown), Lanlan Wei, Fengmin Zhang	15
17	Borna disease virus nucleoprotein inhibits type I interferon induction through the interferon regulatory factor 7 pathway 2013 ·Biochemical and Biophysical Research Communications ·Wuqi Song, Wenping Kao, Aixia Zhai, Jun Qian, Yujun Li, Qingmeng Zhang, Hong Zhao, Yunlong Hu, Hui Li, Fengmin Zhang	10
18	MiR-122 modulates type I interferon expression through blocking suppressor of cytokine signaling 1 2013 ·The International Journal of Biochemistry & Cell Biology ·Aimei Li, Wuqi Song, Jun Qian, Yujun Li, Junming He, Qingmeng Zhang, Wenhui Li, Aixia Zhai, Wenping Kao, Yunlong Hu, Hui Li, Jing Wu, Hong Ling, Zhaohua Zhong, Fengmin Zhang	54
19	Over-expression of mitochondrial antiviral signaling protein inhibits coxsackievirus B3 infection by enhancing type-I interferons production 2012 ·Virology Journal ·(unknown), Wuqi Song, Yujun Li, Jun Qian, Aixia Zhai, Jing Wu, Aimei Li, Junming He, Jinyun Zhao, (unknown), Lanlan Wei, Fengmin Zhang	11
20	Modulation of miR-122 expression affects the interferon response in human hepatoma cells 2012 ·Molecular Medicine Reports ·Aimei Li, Jun Qian, Junming He, Qingmeng Zhang, Aixia Zhai, Wuqi Song, Yujun Li, Hong Ling, Zhaohua Zhong, Fengmin Zhang	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact